• Company Type For Profit
  • Contact Email enquiries@glidepharma.com
  • Phone Number 44 8700 853 700

Glide Pharmaceutical Technologies is a clinical stage development company that focuses on solid dose formulations of therapeutics and vaccines. The company develops SDI, a solid dose injector system to improve compliance in patients self-administering long term therapy. Its pipeline of solid dose formulations includes octreotide, teriparatide, and

anthrax and influenza vaccines. Glide Pharmaceutical Technologies was formerly known as Caretek Medical.

Lists Featuring This Company

Oxford Capital Portfolio Companies
66 Number of Organizations • $2.9B Total Funding Amount • 460 Number of Investors
Closed United Kingdom Health Care Companies
620 Number of Organizations • $5.5B Total Funding Amount • 407 Number of Investors
Oxford Technology Management Portfolio Companies
95 Number of Organizations • $599.5M Total Funding Amount • 327 Number of Investors
Closed Europe Biotechnology Companies
729 Number of Organizations • $6.6B Total Funding Amount • 1,076 Number of Investors

Frequently Asked Questions

Where is Glide Pharmaceutical Technologies's headquarters? Glide Pharmaceutical Technologies is located in Abingdon, Oxfordshire, United Kingdom.Who invested in Glide Pharmaceutical Technologies? Glide Pharmaceutical Technologies has 4 investors including Oxford Capital and Invesco.How much funding has Glide Pharmaceutical Technologies raised to date? Glide Pharmaceutical Technologies has raised .When was the last funding round for Glide Pharmaceutical Technologies? Glide Pharmaceutical Technologies closed its last funding round on Feb 1, 2017 from a Venture - Series Unknown round.